Navigation Links
Interleukin Genetics Reports First Quarter 2009 Financial Results
Date:5/14/2009

teoporosis: Translating Research into Clinical Practice, on April 4 in Washington, D.C. The poster, titled "Identification of Inflammatory Gene Variants as Biomarkers of Osteoporosis Risk in Asian Women," highlighted genetic predisposition risk factors in Asian women for vertebral fractures and osteoporosis.
  • Presented Data Highlighting Link Between Inflammatory Genes and Weight Loss. In January, at a Keystone Symposium titled, "Obesity: Novel Aspects of the Regulation of Body Weight," in Banff, Alberta, Canada, Interleukin Genetics presented new research findings on the role genetics play in an individual's ability to lose weight and body fat while following a calorie-restricted diet. The poster, titled, "Association of genes involved in chronic inflammation with weight management in response to the carbohydrate content of diet under calorie restriction," highlighted the influence of genetic polymorphisms in the genes of interleukin-1 (IL-1) inflammatory pathway on dietary intervention induced weight and body fat loss.

    • Conference Call and Webcast Information

    Interleukin Genetics will host a live conference call and webcast today at 4:30 p.m. EDT to review the Company's new business developments and first quarter financial results. To access the live call, dial 877-397-0291 (domestic) or 719-325-4857 (international). The live webcast and replay access will be available on the Investors section of the Company's website at http://www.ilgenetics.com.

    About Interleukin Genetics

    Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests that empower consumers to prevent chronic diseases of aging and that assist pharma
    '/>"/>

    SOURCE Interleukin Genetics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine news :

    1. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
    2. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
    3. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
    4. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
    5. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
    6. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
    7. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
    8. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
    9. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
    10. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
    11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 1Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 2Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 3Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 4Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 5Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 6Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 7Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 8Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 9Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 10Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 11Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 12Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 13Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 14Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 15Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 16Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 17Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 18Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 19Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 20Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 5441 21Food and Drug Administration Expert to Deliver Keynote Address 5439 1Food and Drug Administration Expert to Deliver Keynote Address 5439 2Frutarom Launches New Global Branding 5437 1Frutarom Launches New Global Branding 5437 2Frutarom Launches New Global Branding 5437 3